06th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200038397 | PHARMACOTHERAPY FOR PREVENTING OR TREATING GLAUCOMA | 2020-02-06 |
20200038398 | COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS | 2020-02-06 |
20200038399 | FORMULATIONS, METHODS, KIT, AND DOSAGE FORMS FOR TREATING BACTERIAL INFECTION | 2020-02-06 |
20200038400 | DRUG EFFECTIVE FOR LYMPHOGENOUS DRUG ADMINISTRATING METHOD | 2020-02-06 |
20200038401 | Therapeutic Compositions | 2020-02-06 |
20200038402 | SUBSTITUTED QUINAZOLINE SULFONAMIDES AS THIOREDOXIN INTERACTING PROTEIN (TXNIP) INHIBITORS | 2020-02-06 |
20200038403 | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR | 2020-02-06 |
20200038404 | METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYL- PROPANENITRILE | 2020-02-06 |
20200038405 | SALTS AND SOLID FORM OF A BTK INHIBITOR | 2020-02-06 |
20200038406 | 7-BENZYL-4-(METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]- PYRIMIDIN-5 (1H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY | 2020-02-06 |
20200038407 | PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE | 2020-02-06 |
20200038408 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2020-02-06 |
20200038409 | AMINOPYRIMIDINYL COMPOUNDS | 2020-02-06 |
20200038410 | METHODS FOR TREATING NEUROPATHY | 2020-02-06 |
20200038411 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | 2020-02-06 |
20200038412 | METHODS OF TREATING ALZHEIMER'S DISEASE USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038413 | METHODS OF TREATING PARKINSON'S DISEASE USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038414 | METHODS OF TREATING CONSTIPATION USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038416 | METHODS OF TREATING CARDIAC CONDUCTION DEFECTS USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038417 | METHODS AND COMPOSITIONS FOR TREATING COGNITIVE IMPAIRMENT | 2020-02-06 |
20200038418 | METHODS OF TREATING AUTISM SPECTRUM DISORDER USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038419 | METHODS OF TREATING MULTIPLE SYSTEM ATROPHY USING AMINOSTEROL COMPOSITIONS | 2020-02-06 |
20200038420 | AMINOSTEROL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING DEPRESSION | 2020-02-06 |
20200038421 | CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USE | 2020-02-06 |
20200038422 | A COMPOSITION WITH MOBILITY BENEFITS IN AGEING, HEALTHY SUBJECTS | 2020-02-06 |
20200038423 | USE OF 6-O-(C8-C20 ALKYL ESTER) OF 1-O-(C1-C6 ALKYL)- -D-GLUCOSIDE AS AN AGENT FOR PROTECTING THE SKIN | 2020-02-06 |
20200038424 | NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES | 2020-02-06 |
20200038425 | MICRORNA 19A/19B FOR USE IN TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH BONE LOSS OR REDUCED MUSCLE FUNCTION | 2020-02-06 |
20200038426 | SYNERGISTIC COMBINATION OF OLIGONUCLEOTIDES AND CHEMOTHERAPEUTIC FOR TREATING CANCER | 2020-02-06 |
20200038427 | CYCLIC NUCLEIC ACID MOLECULE HAVING GENE EXPRESSION CONTROL FUNCTION | 2020-02-06 |
20200038428 | CANCER CELL ADHESION ACTIVITY INHIBITOR | 2020-02-06 |
20200038429 | P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION | 2020-02-06 |
20200038430 | IN VITRO HEPARIN AND HEPARAN SULFATE COMPOSITIONS AND METHODS OF MAKING AND USING | 2020-02-06 |
20200038431 | TREATMENT OF MYELOSUPPRESSION | 2020-02-06 |
20200038432 | HYALURONIC ACID COATED CHIMERIC VIRAL/NONVIRAL NANOPARTICLES | 2020-02-06 |
20200038433 | AQUEOUS COMPOSITION DERIVED FROM SEAWATER AND SEAWEED | 2020-02-06 |
20200038434 | PRODUCT FOR OBESITY TREATMENT | 2020-02-06 |
20200038435 | MINERAL, NUTRITIONAL, COSMETIC, PHARMACEUTICAL, AND AGRICULTURAL COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | 2020-02-06 |
20200038436 | METHOD FOR REDUCING OTOTOXICITY IN PEDIATRIC PATIENTS RECEIVING PLATINUM-BASED CHEMOTHERAPY | 2020-02-06 |
20200038437 | Base Medicinal Formulation for Supporting the Specific Homeostatic Acid-Base Balance of Differentiated Living Tissues | 2020-02-06 |
20200038438 | ANGSTROM SILVER INJECTION FOR CANCER INHIBITION, PREPARATION METHOD AND APPLICATION THEREOF | 2020-02-06 |
20200038439 | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM | 2020-02-06 |
20200038440 | SHORT-TERM ACTIVATED DC1S AND METHODS FOR THEIR PRODUCTION AND USE | 2020-02-06 |
20200038441 | QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES | 2020-02-06 |
20200038442 | CHIMERIC ANTIGEN RECEPTOR THERAPY T CELL EXPANSION KINETICS AND USES THEREOF | 2020-02-06 |
20200038443 | MULTI-FUNCTION AND MULTI-TARGETING CAR SYSTEM AND METHODS FOR USE THEREOF | 2020-02-06 |
20200038444 | MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | 2020-02-06 |
20200038445 | TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS | 2020-02-06 |
20200038446 | Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers | 2020-02-06 |
20200038447 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-02-06 |
20200038448 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-02-06 |
20200038449 | Prevention and treatment of bone and cartilage damage or disease | 2020-02-06 |
20200038450 | Tissue repair by stem cell recruitment and differentiation | 2020-02-06 |
20200038451 | STEM CELLS AS AN INDIVIDUALIZED MATERNAL THERAPY FOR PREVENTION OF PREMATURITY | 2020-02-06 |
20200038452 | Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases | 2020-02-06 |
20200038453 | NEURAL STEM CELL-MEDIATED CANCER TREATMENT | 2020-02-06 |
20200038454 | METHODS AND COMPOSITIONS FOR TISSUE THERAPY AND ANALYSIS | 2020-02-06 |
20200038455 | COMPOSITIONS AND METHODS FOR TREATING DIVERTICULITIS AND RELATED DISORDERS | 2020-02-06 |
20200038456 | Compositions and Methods for the Treatment of Demyelinating Conditions | 2020-02-06 |
20200038457 | IL-12 IMMUNOTHERAPY FOR CANCER | 2020-02-06 |
20200038458 | COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM | 2020-02-06 |
20200038459 | COMPOSITION COMPRISING FECAL MICROBIOTA | 2020-02-06 |
20200038460 | Composition for Alleviating Mental Health Disorder | 2020-02-06 |
20200038461 | LACTIC ACID BACTERIA, METHODS AND USES THEREOF | 2020-02-06 |
20200038462 | METHODS AND COMPOSITIONS OF OTC CONSTRUCTS AND VECTORS | 2020-02-06 |
20200038463 | METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS | 2020-02-06 |
20200038464 | Treatment of Warts | 2020-02-06 |
20200038465 | METHOD OF AGGLOMERATING CANNABIS EXTRACT WITH ENERGIZING CONSUMABLES | 2020-02-06 |
20200038466 | GASTROINTESTINAL RELEASE CAPSULE FOR USE IN A METHOD FOR DESENSITISING AND/OR INDUCING TOLERANCE IN A PATIENT WITH A PEANUT ALLERGY | 2020-02-06 |
20200038467 | NATURAL MOLECULES FROM ARTOCARPUS HIRSUTUS: METHOD OF ISOLATION AND ANTI-ACNE POTENTIAL THEREOF | 2020-02-06 |
20200038468 | COMPOSITIONS CONTAINING PLANT EXTRACTS AND APPLICATIONS THEREOF | 2020-02-06 |
20200038470 | MULTIFUNCTIONAL FORMULATION COMPRISED OF NATURAL INGREDIENTS AND METHOD OF PREPARATION/MANUFACTURING THEREOF | 2020-02-06 |
20200038471 | SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS | 2020-02-06 |
20200038472 | METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION | 2020-02-06 |
20200038473 | Peptides that Block Leukocyte Recruitment and Methods of Use | 2020-02-06 |
20200038474 | COMPOSITION, USE AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES | 2020-02-06 |
20200038475 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | 2020-02-06 |
20200038476 | Low-Dose Stable Formulations of Linaclotide | 2020-02-06 |
20200038477 | MODULATORS OF COMPLEMENT ACTIVITY | 2020-02-06 |
20200038478 | POLYPEPTIDE AND COMPOSITION THEREOF FOR TREATING DISEASES OF METABOLIC SYSTEM | 2020-02-06 |
20200038479 | WOUND HEALING AGENT HAVING ANTIMICROBIAL ACTIVITY AND WOUND HEALING ACCELERATING ACTIVITY | 2020-02-06 |
20200038480 | METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY | 2020-02-06 |
20200038481 | RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION | 2020-02-06 |
20200038482 | COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING | 2020-02-06 |
20200038483 | MATERIAL FOR TREATMENT OF BRAIN INJURY, METHOD FOR TREATMENT OF BRAIN INJURY, MATERIAL FOR REGENERATION OF BRAIN NEURONS, AND METHOD FOR REGENERATION OF BRAIN NEURONS | 2020-02-06 |
20200038484 | Bioconjugation Methods for Targeted in Situ Therapeutic Delivery | 2020-02-06 |
20200038485 | METHOD OF STIMULATING ASYMMETRIC DIVISION OF SATELLITE STEM CELLS | 2020-02-06 |
20200038486 | THERAPEUTIC MEDICINE FOR FIBROUS DISEASE | 2020-02-06 |
20200038487 | PREVENTION AND TREATMENT OF NON-MELANOMA SKIN CANCER (NMSC) | 2020-02-06 |
20200038488 | INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION | 2020-02-06 |
20200038489 | Novel Use of Von Willebrand Factor | 2020-02-06 |
20200038490 | MICROPARTICLES | 2020-02-06 |
20200038491 | METHODS FOR REDUCING LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE | 2020-02-06 |
20200038492 | INITIATING NEUROTOXIN TREATMENTS | 2020-02-06 |
20200038493 | CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY | 2020-02-06 |
20200038494 | COMPOSITION COMPRISING HIGHLY-CONCENTRATED ALPHA1 PROTEINASE INHIBITOR AND METHOD FOR OBTAINING THEREOF | 2020-02-06 |
20200038495 | BREAST CANCER VACCINE | 2020-02-06 |
20200038496 | NOVEL VEGFR-2 TARGETING IMMUNOTHERAPY APPROACH | 2020-02-06 |
20200038497 | KLEBSIELLA PNEUMONIAE CAPSULE POLYSACCHARIDE VACCINES | 2020-02-06 |
20200038498 | Compositions and Methods for Treating an Active Mycobacterium Tuberculosis Infection | 2020-02-06 |